Long-term outcomes of opioid use disorder treatment with extended-release buprenorphine implant: One-year post-removal follow-up
Sarah Vecchio, Sabino Cirulli, Claudio Pierlorenzi, Concettina Varango, Roberta Marenzi, Marco Riglietta, and Valentina Giacon
Interventions for opioid use disorder among adolescents: A systematic review
Suhaib Yehya
Erectile dysfunction in men treated in opioid addiction treatment programs
Nusa Segrec, and Vanja Erculj
The innovation of long-acting injectable buprenorphine in the management of opioid use disorder in prisons: A manifesto shared by experts with delphi panel survey
Sarah Vecchio, Carmelo Cantone, Felice Alfonso Nava, Francesca Sassano, Biagio Sciortino, Gennaro Sosto, Giulio Di Mizio *, and Marco Riglietta *
Nutritional status of heroin addicts undergoing rehabilitation in Sri Lanka. A glimpse into a neglected aspect of drug addiction
Nuwan Darshana, Champa Wijesinghe, and Vijitha De Silva
Alcoholism in heroin use disorder patients. A masked heroin addiction case report
Alessandra Petrucci, Filippo Della Rocca, Manuel Glauco Carbone, Matteo Pacini,
Mario Miccoli, Icro Maremmani, and Angelo G. I. Maremmani,
Pharmacogenomic predictors of sexual dysfunction in Malaysian male opioid users on methadone maintenance treatment
Sim Maw Shin, Shahrzad Riahi, Muhammad Fazril Mohamad Razif, Loh Huai Seng,
and Anne Yee
Self-stigma in Opioid Use Disorder: The roles of depression, hopelessness, anxiety, stress, and resilience
Gamze Zengin İspir, Mehmet Rıdvan Varlı, Mustafa Danışman, Kübra Sezer Katar,
Zehra Uçar Hasanlı, and Mustafa Batuhan Kurtoğlu
Retention rates in opioid maintenance treatment with methadone and buprenorphine – results from a -year observational study
Michael Soyka, Peggy Schmidt, Hans-Ulrich Wittchen, and Gerhard Bühringer,
Sexual dysfunction and its associated factors among male heroin addicts: Evidence from a large cross-sectional study in Sri Lanka
Nuwan Darshana, Champa Wijesinghe, and Vijitha De Silva
Dissociation, childhood trauma and opioid use: A naturalistic follow-up study in a substance use treatment inpatient clinic
Sercan Karabulut, Hatice Genç, and Seyhan Uzar Uçkun
Evaluation of thiol/disulfide homeostasis and ischemia-modified albumin levels in patients diagnosed with heroin use disorder
Safak Yalcin Sahiner, Dilek Baysal, Tugberk Vayisoglu, Gamze Avcioglu,
Fatma Meric Yilmaz, and Ozcan Erel
Tracing the evolution of dual disorders in the era of the opioid crisis. Deconstructing psychiatric orthodoxy
Icro Maremmani, Gianpaolo Spinnato, and Angelo Giovanni Icro Maremmani,
Prevalence of physical co-morbidities in older patients on prescribed opioid agonist treatment: A narrative systematic review
Duncan R. B. Hill, Amanj Kurdi, and Marion Bennie,
Assessing subjective wellness in heroin use disorder with the dm-sws:
A behavioural self-report tool for patients with heroin addiction.
Part I – Theoretical framework, reliability, and exploratory factor analysis
Icro Maremmani, Filippo Della Rocca, Manuel Glauco Carbone, Mario Miccoli,
and Angelo Giovanni Icro Maremmani,
Assessing subjective wellness in heroin use disorder.
Part II. Sensitivity to clinical change and temporal responsiveness of the DM-SWS in opioid-dependent patients
Icro Maremmani, Filippo Della Rocca, Manuel Glauco Carbone, Mario Miccoli,
and Angelo Giovanni Icro Maremmani,
Assessing subjective wellness in heroin use disorder.
Part III: convergent and discriminant validity of the dm-sws.
Correlations with demographics, symptom scales and behavioural questionnaires
Icro Maremmani, Filippo Della Rocca, Manuel Glauco Carbone, Mario Miccoli,
and Angelo G. I. Maremmani,
Diagnostic definitions of overdose and (opioid-induced) respiratory depression relevant to remote monitoring via accelerometry
Alexander Adam, John Dillon, and John Strang
Impact of treatment flexibilization measures on outcome variables in opioid use disorder patients receiving methadone. Lessons learned from the covid- pandemic
Marta Narváez-Camargo, Oscar M. Lozano, Cinta Mancheño-Velasco, Fermin Fernández-Calderón,
Ana De la Rosa Cáceres, and Carmen Díaz-Batanero,
Stigma of opioid addiction: A narcoleptic patient blamed for being excessively sleepy during the day due to her opioid use disorder
Usman Riaz, and Syed Ali Riaz
Cognitive functioning in subjects with substance use disorder: Retrospective observational study on the transition from methadone to levomethadone
Silvia Pinna, Giuseppe Gagliardo, Selene Regio, Francesca Pagliari, Lorenzo Finocchiaro, Maria Cristina Marrone, and Pietro Casella
Predictors of engagement and dropout in the context of joint treatment for dual disorders: An exploratory analysis
Andrea Saverio Spagnuolo, Ottone Baccaredda Boy, Ilaria Noschese, Niccolò Porcinai,
Ferdinando Elia, Giovanni Castellini, Francesco Rotella, Valdo Ricca, Cecilia Lanzi,
Brunella Occupati, Icro Maremmani, Guido Mannaioni, and Andrea Ballerini
Naldemedine’s role in relieving opioid-induced constipation among patients on opioid agonist treatment
Stefano Sacco, Carolina Cappa, Fabio Sacco, Michele Scarzella, and Luigi Bartoletti
Management of patients in an unstable phase of opioid use disorder: Challenges, goals, and emerging evidence on long-acting buprenorphine
Catriona Matheson, Michael Soyka, Bernadette Hard, Georges Brousse, Susanna Meyner, Carola Seibold, and Marta Torrens,
Heroin addicts in opioid agonist treatment programme: years of retrospective period observation of deceased before and after covid syndemic: A naturalistic study
Mercedes Lovrecic, and Barbara Lovrecic,
The impact of agonist opioid treatment on cognitive efficiency in young males with opioid use disorder: An event-related potentials (erp) p analysis
Olga Ivetic, Aleksandra Dickov, Vladimir Knezevic, Dragana Ratkovic, and Masa Comic
Cyclothymia predicts substance use across classes: From alcohol and opioids to cocaine
Matteo Pacini, Marco Maiello, Filippo Della Rocca, Mario Miccoli,
Icro Maremmani, and Angelo G. I. Maremmani,
Weekly long-acting buprenorphine for opioid use disorder in the custody setting: An Italian experience
Dimosthenis Karonis
Psychotic sensitivity in heroin addiction: Evidence for a clinically distinct phenomenon
Angelo Giovanni Icro Maremmani, Filippo Della Rocca, Manuel Glauco Carbone,
Andrea Saverio Spagnuolo, Ottone Baccaredda Boy, Andrea Ballerini, and Icro Maremmani,
Intaud – a network for the treatment of alcohol use disorder, developed within europad
Albrecht Ulmer
The use of Bupropion/Naltrexone in a small sample of female bipolar disorder patients with bulimia nervosa
Manuel Glauco Carbone, Luca Mazzetto, Rossella Miccichè, Alessandro Bellini,
Roberta Rizzato, Giulia Gastaldello, Claudia Tagliarini, Filippo Della Rocca,
and Angelo Giovanni Icro Maremmani,
Not bipolar but under-treated: How high-dose methadone rewrote the clinical narrative
Manuel Glauco Carbone, Giulia Gastaldello, Luca Mazzetto, Alessandro Bellini,
Roberta Rizzato, Rossella Miccichè, Beniamino Tripodi, Claudia Tagliarini,
Filippo Della Rocca, and Angelo Giovanni Icro Maremmani,
Opioid agonist treatment in the era of fentanyl: Reflections from the aatod conference, Philadelphia
Icro Maremmani
